1. Home
  2. BIAF vs MKTW Comparison

BIAF vs MKTW Comparison

Compare BIAF & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • MKTW
  • Stock Information
  • Founded
  • BIAF 2014
  • MKTW 1999
  • Country
  • BIAF United States
  • MKTW United States
  • Employees
  • BIAF N/A
  • MKTW N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MKTW Computer Software: Prepackaged Software
  • Sector
  • BIAF Health Care
  • MKTW Technology
  • Exchange
  • BIAF Nasdaq
  • MKTW Nasdaq
  • Market Cap
  • BIAF 21.4M
  • MKTW 23.1M
  • IPO Year
  • BIAF 2022
  • MKTW N/A
  • Fundamental
  • Price
  • BIAF $1.24
  • MKTW $0.56
  • Analyst Decision
  • BIAF Strong Buy
  • MKTW Buy
  • Analyst Count
  • BIAF 1
  • MKTW 2
  • Target Price
  • BIAF $6.00
  • MKTW $2.50
  • AVG Volume (30 Days)
  • BIAF 102.5K
  • MKTW 549.4K
  • Earning Date
  • BIAF 11-14-2024
  • MKTW 11-07-2024
  • Dividend Yield
  • BIAF N/A
  • MKTW 7.33%
  • EPS Growth
  • BIAF N/A
  • MKTW N/A
  • EPS
  • BIAF N/A
  • MKTW 0.13
  • Revenue
  • BIAF $9,367,785.00
  • MKTW $423,378,000.00
  • Revenue This Year
  • BIAF $302.41
  • MKTW N/A
  • Revenue Next Year
  • BIAF $15.00
  • MKTW N/A
  • P/E Ratio
  • BIAF N/A
  • MKTW $4.09
  • Revenue Growth
  • BIAF 2813.87
  • MKTW N/A
  • 52 Week Low
  • BIAF $1.20
  • MKTW $0.47
  • 52 Week High
  • BIAF $3.62
  • MKTW $3.50
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 36.67
  • MKTW 47.35
  • Support Level
  • BIAF $1.21
  • MKTW $0.49
  • Resistance Level
  • BIAF $1.37
  • MKTW $0.56
  • Average True Range (ATR)
  • BIAF 0.08
  • MKTW 0.05
  • MACD
  • BIAF 0.01
  • MKTW 0.00
  • Stochastic Oscillator
  • BIAF 17.50
  • MKTW 39.06

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About MKTW MarketWise Inc.

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

Share on Social Networks: